Found 177 articles for: "melasma"
A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia
April 2023 | Volume 22 | Issue 4 | Original Article | 333 | Copyright © April 2023
Background: Dyschromia can be caused by abnormalities in the increased production and/or reduced clearance of pigmentation in the skin. Causes of hyperpigmentation include excessive s...
Read MoreWATCH VIDEO ABSTRACT: Scarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols
March 2023 | Volume 22 | Issue 3 | Original Article | 288 | Copyright © March 2023
Read MoreTwo-Step Skincare Regimen Addressing Aging in Three Unique Geographic Locations: A Prospective, Multi-Center, Open-Label Study
January 2023 | Volume 22 | Issue 1 | Original Article | 16 | Copyright © January 2023
Background: Extrinsic factors including solar radiation and air pollution significantly impact facial skin aging. The efficacy and tolerability of a 2-step skincare regimen consisting...
Read MoreScarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols
July 2023 | Volume 22 | Issue 7 | Original Article | 7253 | Copyright © July 2023
Importance: Managing chronic conditions is an essential aspect of dermatologic care, especially regarding the resolution of inflammatory dermatologic disease and recovery of skin lesi...
Read MoreA Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas
December 2022 | Volume 21 | Issue 12 | Original Article | 1304 | Copyright © December 2022
Background: Hydroquinone is effective in melasma treatment, but side effects may limit its use. Silymarin cream may be a safer alternative. Objective: To compare the ...
Read MoreSupplement Individual Article: Racial Ethnic Variations in Acne: A Practical Algorithm for Treatment and Maintenance, Including Skincare Recommendations for Skin of Color Patients With Acne
November 2022 | Volume 21 | Issue 11 | Supplement Individual Articles | SF3446083 | Copyright © November 2022
Background: Racial/ethnic differences in the clinical presentation, sequelae, and desired treatment outcomes for acne have been reported. Post-inflammatory hyperpigmentation (PIH) frequently occurs in...
Read MoreAdvances in Pigmentation Management: A Multipronged Approach
November 2022 | Volume 21 | Issue 11 | Original Article | 1206 | Copyright © November 2022
Background: Key cellular players regulating human skin pigmentation include melanocytes in the epidermis that synthesize melanin, neighboring keratinocytes that receive and distribute...
Read MoreBlue Light and Skin Health
September 2022 | Volume 21 | Issue 9 | Original Article | 962 | Copyright © September 2022
Although blue light has been present in our lives for decades, this type of visible light has recently become a topic of significant interest as we shift to a greater percentage of our time spent in f...
Read MoreA Roadmap for the Development of a Diverse and Inclusive Medical Student Dermatologic Curriculum
August 2022 | Volume 21 | Issue 8 | Editorials | 908 | Copyright © August 2022
The need for diversification in dermatology has been increasingly highlighted. However, until recently there had been a lack of emphasis on the pathway that unites all physicians: medical education. F...
Read MoreOral Tranexamic Acid for the Treatment of Melasma: A Case Series and Novel Dosing Regimen
April 2022 | Volume 21 | Issue 4 | Original Article | 393 | Copyright © April 2022
Melasma is a common disorder affecting millions of people around the world.1 It is a condition that can disrupt one’s self-esteem and overall quality of life.2 Melasma is c...
Read MoreAssessment of Circadian-based Antioxidants Plus a Comprehensive Brightener in Skin of Color Patients With Hyperpigmentation
April 2022 | Volume 21 | Issue 4 | Original Article | 376 | Copyright © April 2022
Background: Hyperpigmentation disorders disproportionately affect individuals with skin of color. There is an unmet need for safe and effective topical treatments for this population....
Read MoreGetting to the Core of Contemporary Therapies for Post-Inflammatory Hyperpigmentation
March 2022 | Volume 21 | Issue 3 | Original Article | 276 | Copyright © March 2022
Post-inflammatory hyperpigmentation (PIH) is a typical complication of inflammatory dermatoses that more frequently and severely affects people with darker skin. External insults to the skin, such as ...
Read MoreA Randomized Trial of Oral Tranexamic Acid With Fluocinolone-Based Triple Cream Versus Fluocinolone Based Triple Cream Alone for the Treatment of Melasma
March 2022 | Volume 21 | Issue 3 | Editorials | 321 | Copyright © March 2022
Oral tranexamic acid (TXA) is a relatively new treatment option for melasma. It is thought to reduce hyperpigmentation through inhibition of the plasminogen/plasmin pathway with resulting decreases in...
Read MoreHistopathological Changes Induced by Malassezin: A Novel Natural Microbiome Indole for Treatment of Facial Hyperpigmentation
February 2022 | Volume 21 | Issue 2 | Original Article | 141 | Copyright © February 2022
Background: Malassezin is a natural indole compound produced by the fungus Malassezia furfur and preclinical investigations have demonstrated an ability to suppress melanogen...
Read MoreTreatment of Hyperpigmented Discoid Lupus Erythematosus With Jessner's Peel: A Case Report
January 2022 | Volume 21 | Issue 1 | Case Reports | 92 | Copyright © January 2022
Discoid lupus erythematosus (DLE) is the most common type of chronic cutaneous lupus erythematosus and is categorized by well-demarcated, often hyper or hypopigmented macules or papules that gradually...
Read MoreTopical Stabilized Cysteamine as a New Treatment for Hyperpigmentation Disorders: Melasma, Post-Inflammatory Hyperpigmentation, and Lentigines
December 2021 | Volume 20 | Issue 12 | Original Article | 1276 | Copyright © December 2021
Cysteamine is an aminothiol naturally present in cells of the human body as an antioxidant resulting from the degradation of Coenzyme A. Physiologically it is well distributed in mammalian tissues. Hi...
Read MoreThe Efficacy and Safety of a Novel Protective Complex Combined With 50% Glycolic Acid Peel: A Double-Blinded, Split Face, Controlled Study
December 2021 | Volume 20 | Issue 12 | Original Article | 1336 | Copyright © December 2021
Background: Glycolic acid (GA) is a commonly used superficial peel with higher concentrations and lower pH levels leading to a stronger effect despite a higher risk of adverse effects...
Read MoreOptimizing Outcomes With the 1550/1927 nm Dual Wavelength Non-Ablative Fractional Laser: Experienced User Recommendations
November 2021 | Volume 20 | Issue 11 | Original Article | 1150 | Copyright © November 2021
Background: Fractional laser treatment was introduced in 2004 as a non-invasive technique to treat sun-damaged and aging skin. Since then, numerous ablative and non-ablative photother...
Read MoreSingle-Center, Prospective, Double-Blind, Evaluator-Blind, non-Randomized, Vehicle-Controlled Trial With a 1927 Nm Non-Ablative Fractionated Laser and Topical 0.05% Tretinoin Lotion for Facial Dyspigmentation and Photodamage
November 2021 | Volume 20 | Issue 11 | Original Article | 1174 | Copyright © November 2021
Background: Dyspigmentation and photodamage are common concerns in patients who seek aesthetic consultation. A number of treatment modalities have been utilized to address this issue....
Read MoreClinical Evidence of Cell-Targeted Topical Therapy for Treating Skin Dyspigmentation
August 2021 | Volume 20 | Issue 8 | Original Article | 865 | Copyright © August 2021
Background: New development of cell-targeted therapies to enable site-specific skin tissue drug delivery may reduce off-target effects, decrease unwanted toxicities, and enhance drug ...
Read MoreMedia and other results for: "melasma"